Section Navigation
Section Navigation
- Module 2 Overview
HIV PrEP In-Depth Topics - 0%Lesson 1
HIV PrEP for Adolescents and Young AdultsActivities- 0%Lesson 2
HIV PrEP for WomenActivities- 0%Lesson 3
HIV PrEP for People Who Inject DrugsLesson 3. HIV PrEP for People Who Inject Drugs
Learning Objective Performance Indicators
- Explain the risk factors and impact of the opioid epidemic that contribute to HIV acquisition among people who inject drugs (PWID) in the United States
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in PWID
- Discuss the clinical management of HIV PrEP for PWID including substance use screening, sexual history, baseline evaluation, PrEP medications, follow-up monitoring, and adherence
- Describe the barriers to HIV PrEP uptake in PWID and the strategies to increase HIV PrEP uptake in PWID
- Provide a rationale for additional services for PWID that address opioid use and mental health disorders, and prevent other viral and bacterial infectious diseases
About this Lesson
Learning Objective Performance Indicators
- Explain the risk factors and impact of the opioid epidemic that contribute to HIV acquisition among people who inject drugs (PWID) in the United States
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in PWID
- Discuss the clinical management of HIV PrEP for PWID including substance use screening, sexual history, baseline evaluation, PrEP medications, follow-up monitoring, and adherence
- Describe the barriers to HIV PrEP uptake in PWID and the strategies to increase HIV PrEP uptake in PWID
- Provide a rationale for additional services for PWID that address opioid use and mental health disorders, and prevent other viral and bacterial infectious diseases
Activities in this Lesson
- Quick ReferenceHIV PrEP for People Who Inject Drugs Core Concepts
- Background
- Epidemiology of HIV among PWID
- Factors Associated with Increased Risk for HIV Among PWID
- Evidence for HIV PrEP Among PWID
- Assessing Indications for HIV PrEP Among PWID
- Recommended HIV PrEP Medications for PWID
- Baseline Laboratory Evaluation
- Time to Achieve Protection
- Follow-Up and Laboratory Monitoring
- Implementation of HIV PrEP for PWID
- Additional Care Services for PWID
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) provided financial support for this (website, PowerPoint, podcast, mini-lecture, etc.). The award provided 100% of total costs and totaled $299,994 from HRSA and $603,203 from CDC. The contents are those of the author. They may not reflect the policies of HRSA, HHS, CDC, or the U.S. Government.
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: prepc-monorepo-511d43de-2025-10-09-204027
Become a New User
Account Registration Benefits:
- Track your progress on the lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started